Top Markets
Coin of the day
Ainos, Inc. Ainos, Inc.

Ainos, Inc.

AIMD
Rank in Stocks #32150
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Share Price
$1.49
Last synced: 2026-08-17
Market Cap
$10.94M
Change (1 day)
4.58%
Change (1 year)
-55.67%
Country
US
Trade Ainos, Inc. (AIMD)

Category

Stock split history for Ainos, Inc. (AIMD)
Ainos, Inc. stock (symbol: AIMD) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 18, 2026.
One AIMD share bought prior to Aug 18, 2026 would equal to 0 AIMD shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR